ÂÜÀòÂÒÂ×

Matthieu Carer currently serves as the General Manager for Stemline Therapeutics in France, Belgium, Netherlands, and Luxembourg since January 2022, focusing on the launch and leadership of the company's operations in these regions. Prior to this role, Matthieu Carer spent nearly 16 years at AstraZeneca, holding various senior positions including Global Head of Forxiga, where strategic development and launch coordination for cardiology and nephrology were key responsibilities. Other notable roles at AstraZeneca included Business Unit Director for Respiratory & Immunology, overseeing P&L management and the launch of key products like Fasenra® and LYNPARZA®, and National Sales Director for Oncology, leading significant product launches and strategic partnerships. Matthieu Carer's early career included a position at Merck as a Junior Clinical Research Assistant. Educational credentials include a Medical Doctor degree from Sorbonne Université and a Master in Pharmaceutical Marketing from ESCP Business School.